Rothschild Investment LLC’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$660 Buy
300
+150
+100% +$330 ﹤0.01% 2644
2025
Q1
$174 Buy
150
+20
+15% +$23 ﹤0.01% 2881
2024
Q4
$165 Buy
130
+105
+420% +$133 ﹤0.01% 2828
2024
Q3
$85 Hold
25
﹤0.01% 2861
2024
Q2
$117 Buy
25
+10
+67% +$47 ﹤0.01% 2688
2024
Q1
$111 Buy
+15
New +$111 ﹤0.01% 2159
2020
Q4
Sell
-8,050
Closed -$226K 460
2020
Q3
$226K Sell
8,050
-300
-4% -$8.42K 0.02% 377
2020
Q2
$247K Buy
+8,350
New +$247K 0.03% 350
2020
Q1
Sell
-9,150
Closed -$271K 438
2019
Q4
$271K Sell
9,150
-200
-2% -$5.92K 0.03% 378
2019
Q3
$213K Hold
9,350
0.02% 354
2019
Q2
$231K Hold
9,350
0.03% 341
2019
Q1
$229K Hold
9,350
0.03% 339
2018
Q4
$213K Sell
9,350
-200
-2% -$4.56K 0.03% 334
2018
Q3
$304K Buy
9,550
+200
+2% +$6.37K 0.04% 297
2018
Q2
$335K Buy
9,350
+1,700
+22% +$60.9K 0.04% 282
2018
Q1
$254K Sell
7,650
-900
-11% -$29.9K 0.03% 325
2017
Q4
$263K Buy
+8,550
New +$263K 0.03% 353